Di Wang

3.3k total citations
97 papers, 1.9k citations indexed

About

Di Wang is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Di Wang has authored 97 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 31 papers in Oncology and 17 papers in Hematology. Recurrent topics in Di Wang's work include CAR-T cell therapy research (22 papers), Multiple Myeloma Research and Treatments (10 papers) and Acute Myeloid Leukemia Research (6 papers). Di Wang is often cited by papers focused on CAR-T cell therapy research (22 papers), Multiple Myeloma Research and Treatments (10 papers) and Acute Myeloid Leukemia Research (6 papers). Di Wang collaborates with scholars based in China, United States and Germany. Di Wang's co-authors include Liegang Liu, Chunrui Li, Ping Yao, Wei Bao, Jiwei Liu, Andreas K. Nüssler, Yi Xiao, Wei Yang, Jianfeng Zhou and Hong Yan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Di Wang

92 papers receiving 1.8k citations

Peers

Di Wang

ONCOL

IMMUN

Weijia Zhang China

Yangyang Ding China

Wei Qin China

Yu Ke China

Ying Nie China

Qianqian Liang China

Weiwei Zhang China

Fei Gao China

Hongyu Wu China

Yao Li China

Weijia Zhang China

Di Wang

1.3k ×2.2

345 ×0.7

ONCOL

236 ×1.0

IMMUN

201 ×0.8

161 ×0.7

Citations per year, relative to Di Wang Di Wang (= 1×) peers Weijia Zhang

Countries citing papers authored by Di Wang

Since Specialization

Citations

This map shows the geographic impact of Di Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Wang more than expected).

Fields of papers citing papers by Di Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Wang. The network helps show where Di Wang may publish in the future.

Co-authorship network of co-authors of Di Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Di Wang. A scholar is included among the top collaborators of Di Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Wang. Di Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Yang, Di Wang, & Chunrui Li. (2025). Harnessing Cellular Immunotherapy for EBV‐Associated Malignancies: Current Advances and Future Directions. Journal of Cellular and Molecular Medicine. 29(10). e70603–e70603. 1 indexed citations

Wang, Di, et al.. (2024). Fire Carbon Cycle Research Is on the Rise: A Bibliometric Analysis from 1989–2023. Fire. 8(1). 4–4.

Long, Xiaolu, Ning An, Chunhui Li, et al.. (2024). Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy. Frontiers in Medicine. 11. 1363805–1363805. 1 indexed citations

Qin, Chuan, Ming‐Hao Dong, Luo‐Qi Zhou, et al.. (2024). Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy. Proceedings of the National Academy of Sciences. 121(6). e2315990121–e2315990121. 42 indexed citations

Xu, Yanjie, Xia Mao, Yimei Que, et al.. (2023). The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma. BMC Cancer. 23(1). 123–123. 5 indexed citations

Yang, Liu, Di Wang, Jinlong Hu, & Guoli Zhu. (2023). Classifying Rock Fragments Produced by Tunnel Boring Machine Using Optimized Convolutional Neural Network. Rock Mechanics and Rock Engineering. 57(3). 1765–1780. 9 indexed citations

Ma, Jinze, Ping Jiang, Yong Huang, et al.. (2023). Oxidative stress contributes to flumioxazin-induced cardiotoxicity in zebrafish embryos. Environmental Toxicology and Chemistry. 42(12). 2737–2746. 4 indexed citations

Qin, Chuan, Dai‐Shi Tian, Luo‐Qi Zhou, et al.. (2023). Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal Transduction and Targeted Therapy. 8(1). 5–5. 93 indexed citations

Wang, Di, He Li, Chunhui Li, et al.. (2023). Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases. BMC Infectious Diseases. 23(1). 109–109. 2 indexed citations

10.

Wang, Na, Gaoxiang Wang, Liang Huang, et al.. (2022). CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation. Cytotherapy. 24(8). 841–849. 14 indexed citations

11.

Zhou, Lanlan, et al.. (2022). Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia. Frontiers in Oncology. 12. 912689–912689. 1 indexed citations

12.

Cheng, Yuhang, Di Wang, Menglei Xu, et al.. (2021). Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function. Current Medical Science. 41(3). 474–481. 16 indexed citations

13.

Wu, Xiaohua, Jianqing Zhu, Jun Wang, et al.. (2020). 820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC). Annals of Oncology. 31. S619–S620. 2 indexed citations

14.

Wang, Di, Xiaofeng Yang, S. Henry, et al.. (2019). Impact of Regional Nodal Irradiation and Hypofractionated Whole-Breast Radiation on Long-Term Breast Retraction and Poor Cosmetic Outcome in Breast Cancer Survivors. Clinical Breast Cancer. 20(1). e75–e81. 8 indexed citations

15.

Song, Guiyu, Quan Na, Di Wang, & Chong Qiao. (2017). Microarray expression profile of lncRNAs and mRNAs in the placenta of non-diabetic macrosomia. Journal of Developmental Origins of Health and Disease. 9(2). 191–197. 11 indexed citations

16.

Li, Ruidong, Yaxin Wang, Zhijun Ma, et al.. (2016). Maresin 1 Mitigates Inflammatory Response and Protects Mice from Sepsis. Mediators of Inflammation. 2016. 1–9. 48 indexed citations

17.

Shang, Zhen, Jue Wang, Di Wang, et al.. (2013). Establishment of xenotransplantation model of human CN-AML with FLT3-ITD mut /NPM1 − in NOD/SCID mice. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(3). 329–334. 1 indexed citations

18.

Geng, Zhe, Heng Zhang, Di Wang, et al.. (2012). Combination of cytogenetic analysis and molecular screening in patients with de novo acute myeloid leukemia. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(4). 501–510. 1 indexed citations

19.

Guo, Xiaozhong, Di Wang, Xiaodong Shao, et al.. (2009). Transplantation of autologous bone marrow stem cells in treatment of patients with decompensated cirrhosis. Zhonghua xiaohua zazhi. 29(7). 433–436.

20.

He, Juan, Yibo Hu, Lian Duan, et al.. (2006). Sensitive and selective liquid chromatography–mass spectrometry method for the quantification of rosiglitazone in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 580–585. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact